Home   >  
Protease/Metabolic Enzyme
  >  
ROR

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

ROR

Chemical Structure Cat. No. Product Name CAS No.
GSK805 Chemical Structure
BCP31149 GSK805 1426802-50-7
GSK805 is a potent, orally bioavailable RORγγ Inhibitor with pIC50 of 8.4 and >8.2 for RORγ FRET assay and Th17 assay.
Vimirogant Chemical Structure
BCP30659 Vimirogant 1802706-04-2
Vimirogant is a RORγ inhibitor extracted from patent US 9481674 B1, has a Ki of <100 nM.
SR-0987 Chemical Structure
BCP29012 SR-0987 303126-97-8
SR-0987 is a T cell-specific RORγ (RORγt) agonist.
GSK2981278 Chemical Structure
BCP17156 GSK2981278 1474110-21-8
GSK 2981278 (GSK2981278) is a potent, highly selective RORγ/RORγt inhibitor that potently inhibits IL-17A and IL-22 protein secretion in human peripheral T cell with IC50 of 3.2 nM.
SR 1001 Chemical Structure
BCP09202 SR 1001 1335106-03-0
Retinoic acid receptor-related orphan receptors (ROR) α and γ inverse agonist (Ki values are 172 and 111 nM for RORα and RORγ respectively). Demonstrates no activity at RORβ or LXR. Suppresses TH17 cell differentiation and cytokine expression and reduces the severity of disease in an animal model of mulitple sclerosis.
SR3335 Chemical Structure
BCP13177 SR3335 293753-05-6
SR3335 is a selective RORα synthetic ligand, directly binds to RORα (Ki 220 nM) but not other RORs, and functions as a selective partial inverse agonist of RORα in cell-based assays.
Cintirorgon Chemical Structure
BCP28882 Cintirorgon 2055536-64-4
Cintirorgon (LYC-55716) is novel oral RAR-related orphan receptor γ (RORγ) agonist.
Cintirorgon sodium Chemical Structure
BCP30762 Cintirorgon sodium 2055538-47-9
Cintirorgon (LYC-55716) is novel oral RAR-related orphan receptor γ (RORγ) agonist.
SR 1078 Chemical Structure
BCP09203 SR 1078 1246525-60-9
SR1078 is a newly described synthetic RORα/γ agonist.
0086-15971444841